Radiotherapy may enhance the presentation of these antigens by dendritic cells, leading to a stronger immune response as well as modulating the tumor microenvironment by increasing the expression of immune checkpoint molecules such as PD-L1, potentially making tumors more responsive to immunotherapy. Here, CD274 is linked to neoplasm.